Metraipolis › archive › dc_0c1e8a79e06b

Clinical Translation of Fisetin for Age-Related Diseases: Current Evidence and Future Opportunities — Europe PMC PMID:42796982

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42796982
DOI
10.3390/nu18182999
License (as archived)
solo-consultazione
Archived
2026-10-08T17:10:17.734Z
SHA-256 of the archived text
f4477a08571f826b6bd73cbefdf1e0fa7c1507fa468ae085397b9ea6294ccfb1
Stable URL of this page
https://metraipolis.com/documento/dc_0c1e8a79e06b

How to cite

Clinical Translation of Fisetin for Age-Related Diseases: Current Evidence and Future Opportunities — Europe PMC PMID:42796982 — Europe PMC (en), https://europepmc.org/article/MED/42796982 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0c1e8a79e06b (Metraipolis archive dc_0c1e8a79e06b, sha256 f4477a08571f826b6bd73cbefdf1e0fa7c1507fa468ae085397b9ea6294ccfb1)
BibTeX
@misc{dc0c1e8a79e06b,
  title = {Clinical Translation of Fisetin for Age-Related Diseases: Current Evidence and Future Opportunities — Europe PMC PMID:42796982},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42796982},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0c1e8a79e06b; sha256 f4477a08571f826b6bd73cbefdf1e0fa7c1507fa468ae085397b9ea6294ccfb1},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42796982. Agents can read the archived copy with the MCP tool read_document.